FRA10AC1

FRA10A associated CGG repeat 1, the group of Spliceosomal C complex

Basic information

Region (hg38): 10:93667883-93702592

Previous symbols: [ "C10orf4" ]

Links

ENSG00000148690NCBI:118924OMIM:608866HGNC:1162Uniprot:Q70Z53AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalitieARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic34694367; 35821753; 35871492

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FRA10AC1 gene.

  • Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities (2 variants)
  • not provided (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FRA10AC1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
8
clinvar
1
clinvar
9
nonsense
2
clinvar
2
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
0
non coding
0
Total 3 1 9 1 0

Highest pathogenic variant AF is 0.0000463

Variants in FRA10AC1

This is a list of pathogenic ClinVar variants found in the FRA10AC1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-93681495-T-G Uncertain significance (Apr 07, 2023)2662776
10-93681512-G-A Inborn genetic diseases Uncertain significance (May 20, 2024)3279724
10-93681588-T-C Inborn genetic diseases Likely benign (Sep 09, 2021)2248902
10-93684062-T-C Inborn genetic diseases Uncertain significance (May 24, 2024)3279725
10-93685300-C-T Inborn genetic diseases Uncertain significance (Apr 08, 2024)3279723
10-93685309-T-TTAAA Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities Pathogenic (Nov 04, 2022)1722514
10-93685311-T-C Uncertain significance (Apr 07, 2023)2663156
10-93687418-ACTT-A Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities Pathogenic (Sep 26, 2023)1722515
10-93687434-G-A Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities • See cases Pathogenic (Aug 14, 2024)1722518
10-93692034-T-G Inborn genetic diseases Uncertain significance (Dec 03, 2024)3516975
10-93692066-A-T FRA10AC1-related condition Uncertain significance (Sep 11, 2024)3346659
10-93692645-C-T Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities Likely pathogenic (Mar 29, 2024)3064736
10-93692698-G-A Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities Pathogenic (Nov 04, 2022)1722516
10-93692719-T-C Inborn genetic diseases Uncertain significance (Sep 22, 2023)3096671
10-93694867-C-T Inborn genetic diseases Uncertain significance (Apr 25, 2022)2361347
10-93694870-T-C Inborn genetic diseases Likely benign (Mar 15, 2024)3279722
10-93694874-A-C Inborn genetic diseases Uncertain significance (Jun 04, 2024)2207080
10-93694874-A-G Inborn genetic diseases Uncertain significance (Dec 08, 2023)3096670
10-93694925-T-C Inborn genetic diseases Uncertain significance (Nov 07, 2024)2345985
10-93698144-T-C Inborn genetic diseases Uncertain significance (Jan 23, 2023)2478198
10-93698183-T-G See cases Uncertain significance (Nov 25, 2022)2430334
10-93698371-G-A Pathogenic (Jul 30, 2024)2504404
10-93698380-A-C Inborn genetic diseases Uncertain significance (Nov 14, 2024)3516974
10-93698384-A-C Inborn genetic diseases Uncertain significance (Jun 07, 2024)3279726
10-93699997-TGAAAAATAGATCAATAAAAAAAAATTACTTACCTTTTTTTCCTTTTGCTGGATTCTCCACAGCGTTCATCATCACTAAAATCAGAATCATAGCCTCCATGACCATGCATCTGTAAAGGAGTACAAAGTCAGCTATTTAGAATCTATGTTGCCAATTGTCCAGGAAACAATAATTCAAAAATAAGTTATCTTAAACAGCCACAATAGTTTTAAAGGATCATTGTGGGCAGATTCCTATTCACAGGCCATCTAGCCATCTAAAACTTTCATTCGCTTTTAAATAAGAGACATACCTTTCAGGAAATGCATCAACATTTTTCACCCTTAATTATCATTAGGTGAACAAAGAAGGCTACTCTTTGATCTTTTCACTGAAAAACCAGGCCTAAAAGCTGCAGTGACTGCTTACAAGGTTTAGCAATCCTTCACTTTTGATTCAGAGTAGTAATAATCACTGTGTGTTTATCACCAACTTTGTTCTAGACATTGTGTTAAATACTTTACAAACAACACTTCTAATTCTGCAAGTTAGAAAGTTATCTTCATTTAGGAATGAAGTAATCAAAGTTAAGTAAATCTATTTACAAATCCAGTAAGTGGCTAATCTGCTGTACTTGATTCCTGCGCCCACAATTTCAATTACTCCAAATTTCCTCTCTGGAATATGATTTACTATATTCCAGGAGAATTACAGTATTTGTGAACAGTACATCATCAATTGATGAAAATTTTCCTGTAATCTTTTTCAATATATGTAGAGATTTCCATTTTCTTTTGAGTTTCTTTAAGGTAAACCACCTTGCCCTTTGGATTAGTCAGCTTTCTCTTGTTTCATTTTATTTATCCAGTTATTTTTGGAGAGTCTCGCTCTATTGCTCAGGCTGGAGTGCTGTGGCGCCTTGATGGCTCACATCCTCAACCTCCTGGGCTCAATCAATCCTCCCACCTCAGCCTCTCCAAGTAGCTGAGACTACAGGAGTGCATAATCACACCTGGCAAACTTAAAAAAATTTTTTTTTTGTAGATAAGGGGTTTCGCCATGTTGCCCACGCCGGTCTCAAACTCCTGGGCTTGAGCAATCCGTCCACCTCAGCATCCCAAAATGCTGGGACTTCATTTTAGAACTGAAATTCTTAGAAATGCTGGAAGACCTCAGTTGCCACTCAATTGTATTGGAAGAAGCTCCTAGTTCCAGCTTTGCACTGAATTTGGAACACACACTAAGAAGGAAGGATGGACTATTTGATGTCATACATAACTAATTTACATGGCTGGAAGGAACAGTCCAGGTTAAATGATATATCAAATTGTTAAAACTAATATAACGACAGCAAGTGCAGCTGGAAAAAGAGGAAAGAACTCTCTAAACTTCATTGCATTGGATCTAGGGTAAACGACATGTTTCTAGTCCTGGCTACCTTGAATAAGTCATTTCATCTCCCTGGACTTCATCTATTAAATAAGATAGCTACATGAAATAATCTTTAAGTTGTTTAAATCTTTAAATAACCTTTAAAGTCTGTAATTCCATTTTCAAACATAGGTGTGTGGGTATATACCTCTCTTCTCTGCCCCACTAAAATCCTAGATAGGAAGATGCTAGTTAAGGTTGGAGATGAAGGTTTGAAAGCCCGAGTTCCAACTCTACCCTCCCTTACATCTGTTATTGCCTTACACACCTGGATTTTACACCCTTTTTTAGGTCAACTCCAGCTGTCTTACCACATCTGTTCAAGCCATATTGTCCTCTCACTCTTTGTCCTATGTCCTCACGTTCTTTACATCTTGATGGGGGACAGCTGTAGTGTGTTTAGAGATATATTCTAGGATCAGCCTACTAGATTTCACTGCTTGGCTCTGCACTTTCCATTTGTCTTTCTTTGGGCCTGTTCCTTAACCTCTCCAAGCCTCAGTGTCCTCATTTATAAAAAGAGGCTAGTAAGATGGCTGACCTCATACGAATGGAGATTAAAAGAGTTGCCTCATCTAAAGGGTTTTAACGGTGTCTTGTACAGTGAAACCCAGTAAATGTTACATCATCATCATCATCTTTTCCCTCGCCCCAGGACACGACTTCCTATTCTTGCTCCCACTCTCCCATTTCTTTATTCGCTGGCCGCTCCATCCGACCCATACCTATCTTAACTCACTGGTTGAACTAAAAAGCTCTCACTCACTTCAGGCCTACGAATCAACTGACAAGAGCGGGGAGAAACTCAAAAACGGAGATGCCAGGTGTCTCCAGAATCTGTCATCCAAAAAAAAAAAAACCAAACCAAAACAAAAAAAAACCCGACGATCAGCTAGTACTATATGAAAAACAAGTTTTGAGGTCCTTCTCCCTGATGCCAAATATACCCACAGCCCTCCTCACACACCCTTTCCCTTCCTCCCTGTGTGCCAAGTTCGCCCCCGGAGTCGTCGTTTCCTTCTTTCCCGGCAGCTGCAGCGACGACCCACGGCCTGAGAGAGCCGCTGCAGCACAGGTCCCGTGCGCCCTGCCGCACAGCCTCGCCACAACCACCACCGCCGCCGCCGCCGCCGCCGCCGCCCGCAACCCGCCTCTCCCTACGGGTCCCGACTGGGCACCACTTCCGGTCCGACACGGCCACGTGTTACATCTAAATGGCACCGTCCCCCGAGTGCGCCGACCTTGTGCTACAGCCAGAACAGCTCCGGGAAACAAGGGCAGCGGGAGAAACGGCCCGGAAAGGGACGAAGAGGCTTCCAGCTTTCGCCAAGTCGCGGCTCCCAGTTTTTCCCTGGGCCTCCTTCCTTTCCCCTCTAGGGAATCCGGCATCTAGTACCGCTGGCACTGCTTGCTGCTTAGCCCACGCCTCTCATTTGAAAATATATTTTGTTTTACCGTGCCTATCACCTGCCGTCCTCTCTCTAGTAACCTTAGTAACGCCTCCTCGGAG-T Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities Pathogenic (Nov 04, 2022)1722513

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FRA10AC1protein_codingprotein_codingENST00000359204 1334690
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.91e-100.3701256840561257400.000223
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4751281440.8890.000006592084
Missense in Polyphen3545.4960.76929656
Synonymous2.682447.40.5060.00000222464
Loss of Function0.9621721.90.7780.00000102320

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006760.000639
Ashkenazi Jewish0.000.00
East Asian0.0006390.000598
Finnish0.00004670.0000462
European (Non-Finnish)0.0002030.000193
Middle Eastern0.0006390.000598
South Asian0.0003150.000294
Other0.000.00

dbNSFP

Source: dbNSFP

Recessive Scores

pRec
0.0830

Intolerance Scores

loftool
rvis_EVS
0.75
rvis_percentile_EVS
86.57

Haploinsufficiency Scores

pHI
0.122
hipred
Y
hipred_score
0.675
ghis
0.464

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.731

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumHigh

Mouse Genome Informatics

Gene name
Fra10ac1
Phenotype

Gene ontology

Biological process
Cellular component
nucleus
Molecular function
protein binding